(Q39682984)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

title

Reduced DNAM-1 expression on bone marrow NK cells associated with impaired killing of CD34+ blasts in myelodysplastic syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Karl-Johan Malmberg

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

author name string

B C Baumann

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Simonsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

M Jädersten

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

A-M Forsblom

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

C Hammarstedt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

Y T Bryceson

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

H-G Ljunggren

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

E Hellström-Lindberg

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

publication date

8 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

page(s)

1607-1616

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2010.149

7 February 2020

exact match

0 references

cites work

CD56brightCD16- killer Ig-like receptor- NK cells display longer telomeres and acquire features of CD56dim NK cells upon activation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

Promoter hypermethylation of p15INK4B, HIC1, CDH1, and ER is frequent in myelodysplastic syndrome and predicts poor prognosis in early-stage patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

A comparative study of molecular mutations in 381 patients with myelodysplastic syndrome and in 4130 patients with acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Activation of cytotoxic T-cell receptor gammadelta T lymphocytes in response to specific stimulation in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

The role of the immune system in myelodysplasia: implications for therapy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

The myelodysplastic syndrome(s): a perspective and review highlighting current controversies

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

The evolution of hematopoietic SCT in myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Immune mediated autologous cytotoxicity against hematopoietic precursor cells in patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Efficacy of lenalidomide in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

IL-15 trans-presentation promotes human NK cell development and differentiation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

The biology of human natural killer-cell subsets

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Line of attack: NK cell specificity and integration of signals

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Accelerated tumor growth in mice deficient in DNAM-1 receptor

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Natural killer cell-mediated lysis of freshly isolated human tumor cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Low NKp30, NKp46 and NKG2D expression and reduced cytotoxic activity on NK cells in cervical cancer and precursor lesions.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Low expression of CD161 and NKG2D activating NK receptor is associated with impaired NK cell cytotoxicity in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Primary human tumor cells expressing CD155 impair tumor targeting by down-regulating DNAM-1 on NK cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Reduced natural killer (NK) function associated with high-risk myelodysplastic syndrome (MDS) and reduced expression of activating NK receptors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Melanoma-associated fibroblasts modulate NK cell phenotype and antitumor cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Natural killer (NK)-cell activity and antibody-dependent cellular cytotoxicity (ADCC) in primary preleukemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Cytolytic function and survival of natural killer cells are severely altered in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Natural killer cell activity in preleukaemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2010.149

1 reference

7 January 2021

Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Involvement of natural killer cells in patients with myelodysplastic syndrome carrying monosomy 7 revealed by the application of fluorescence in situ hybridization to cells collected by means of fluorescence-activated cell sorting

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Deficient expression of NCR in NK cells from acute myeloid leukemia: Evolution during leukemia treatment and impact of leukemia cells in NCRdull phenotype induction.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Altered NKG2D function in NK cells induced by chronic exposure to NKG2D ligand-expressing tumor cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Impairment of NK cell function by NKG2D modulation in NOD mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Transfer of NKG2D and MICB at the cytotoxic NK cell immune synapse correlates with a reduction in NK cell cytotoxic function

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Biological significance of proliferation, apoptosis, cytokines, and monocyte/macrophage cells in bone marrow biopsies of 145 patients with myelodysplastic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

NKG2D ligand expression in AML increases in response to HDAC inhibitor valproic acid and contributes to allorecognition by NK-cell lines with single KIR-HLA class I specificities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Activated natural killer cells from patients with acute myeloid leukemia are cytotoxic against autologous leukemic blasts in NOD/SCID mice.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

NKG2D-mediated immunity underlying paroxysmal nocturnal haemoglobinuria and related bone marrow failure syndromes

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.149

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.149

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20613786%20AND%20SRC:MED&resulttype=core&format=json

7 February 2020

1 reference